← Back

THREAD Enhances Capabilities for Digital Therapeutics Studies

THREAD Enhances Digital Therapeutics (DTx) Studies with Clinical Research Technology

Read the Press Release >

Digital Therapeutics (DTx) studies require more from clinical research technology. They need connected workflows that integrate the DTx experience with clinical data collection, participant engagement, and study oversight.

THREAD has enhanced its platform with purpose-built capabilities designed specifically for DTx studies, helping sponsors and CROs reduce complexity while generating high-quality clinical evidence.

With THREAD's configurable, no-code platform, DTx developers can:

  • Simplify integrations with DTx platforms, connected devices, sensors, and wearables.
  • Unify data collection across eCOA, eDiaries, eConsent, eCRFs, and virtual visits.
  • Improve participant engagement with coordinated study and DTx notifications that minimize unnecessary interventions.
  • Gain real-time visibility into study performance, adherence, and patient outcomes.

By bringing DTx technology and clinical research workflows together, THREAD helps sponsors accelerate study execution while maintaining a seamless participant experience. Read the Full Announcement >